Alexander S Plattner, Christine R Lockowitz, Rebecca G Same, Monica Abdelnour, Samuel Chin, Matthew J Cormier, Megan S Daugherty, Alexandra E Grier, Nicholas B Hampton, Mackenzie R Hofford, Sarah S Mehta, Jason G Newland, Kevin S O'Bryan, Matthew M Sattler, Mehr Z Shah, G Lucas Starnes, Valerie Yuenger, Alysa G Ellis, Evan E Facer
{"title":"关于CDS失败的特刊:一个轻率的决定:在没有足够临床医生支持的情况下实施ehr整合青霉素过敏去标签协议。","authors":"Alexander S Plattner, Christine R Lockowitz, Rebecca G Same, Monica Abdelnour, Samuel Chin, Matthew J Cormier, Megan S Daugherty, Alexandra E Grier, Nicholas B Hampton, Mackenzie R Hofford, Sarah S Mehta, Jason G Newland, Kevin S O'Bryan, Matthew M Sattler, Mehr Z Shah, G Lucas Starnes, Valerie Yuenger, Alysa G Ellis, Evan E Facer","doi":"10.1055/a-2595-4849","DOIUrl":null,"url":null,"abstract":"<p><p>Approximately 10% of patients have a documented penicillin \"allergy\"; however, up to 95% have subsequent negative testing. These patients may receive suboptimal antibiotics, leading to longer hospitalizations and higher costs, rates of resistant and nosocomial infections, and all-cause mortality. To mitigate these risks in children, we implemented an inpatient penicillin allergy delabeling protocol and integrated it into the electronic health record (EHR) through a mixed methods approach of clinical decision support (CDS).We describe our protocol implementation across three sequential phases: \"Pilot,\" \"Active Antimicrobial Stewardship Program (ASP),\" and \"Mixed CDS.\" We highlight several potential pitfalls that may have contributed to poor clinician adoption.Patients were risk-stratified as nonallergic, low-risk, or high-risk based on history. Process measures included: evaluation rate, oral challenge rate for low-risk, and allergy referral rate for high- or low-risk when oral challenge was deferred. The primary outcome measure was the penicillin allergy delabeling rate among low-risk or nonallergic. Balancing measures included the rate of epinephrine or antihistamine administrations.The pilot and ASP phases used clinician education and an order set, but were mostly manual processes. The mixed CDS phase introduced interruptive alerts, dynamic text in note templates, and patient list columns to guide clinicians, but little education was provided. The mixed CDS phase had the lowest evaluation rate compared with the pilot and active ASP phases (6.4 vs. 25 vs. 15%). However, when the evaluation was performed, the mixed CDS phase had the highest oral challenge rate (33 vs. 26 vs. 13%) and delabeling rate (43 vs. 33 vs. 27%). No adverse events occurred.CDS tools improve clinician decision-making and optimize patient care. However, relying on CDS for complex clinical evaluations can lead to failure when clinicians cannot find the tool or appreciate its importance. Person-to-person communication can be vital in establishing a process and educating intended users for successful CDS implementation.</p>","PeriodicalId":48956,"journal":{"name":"Applied Clinical Informatics","volume":" ","pages":"1095-1103"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12431808/pdf/","citationCount":"0","resultStr":"{\"title\":\"A Rash Decision: Implementing an EHR-Integrated Penicillin Allergy Delabeling Protocol without Adequate Clinician Support.\",\"authors\":\"Alexander S Plattner, Christine R Lockowitz, Rebecca G Same, Monica Abdelnour, Samuel Chin, Matthew J Cormier, Megan S Daugherty, Alexandra E Grier, Nicholas B Hampton, Mackenzie R Hofford, Sarah S Mehta, Jason G Newland, Kevin S O'Bryan, Matthew M Sattler, Mehr Z Shah, G Lucas Starnes, Valerie Yuenger, Alysa G Ellis, Evan E Facer\",\"doi\":\"10.1055/a-2595-4849\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Approximately 10% of patients have a documented penicillin \\\"allergy\\\"; however, up to 95% have subsequent negative testing. These patients may receive suboptimal antibiotics, leading to longer hospitalizations and higher costs, rates of resistant and nosocomial infections, and all-cause mortality. To mitigate these risks in children, we implemented an inpatient penicillin allergy delabeling protocol and integrated it into the electronic health record (EHR) through a mixed methods approach of clinical decision support (CDS).We describe our protocol implementation across three sequential phases: \\\"Pilot,\\\" \\\"Active Antimicrobial Stewardship Program (ASP),\\\" and \\\"Mixed CDS.\\\" We highlight several potential pitfalls that may have contributed to poor clinician adoption.Patients were risk-stratified as nonallergic, low-risk, or high-risk based on history. Process measures included: evaluation rate, oral challenge rate for low-risk, and allergy referral rate for high- or low-risk when oral challenge was deferred. The primary outcome measure was the penicillin allergy delabeling rate among low-risk or nonallergic. Balancing measures included the rate of epinephrine or antihistamine administrations.The pilot and ASP phases used clinician education and an order set, but were mostly manual processes. The mixed CDS phase introduced interruptive alerts, dynamic text in note templates, and patient list columns to guide clinicians, but little education was provided. The mixed CDS phase had the lowest evaluation rate compared with the pilot and active ASP phases (6.4 vs. 25 vs. 15%). However, when the evaluation was performed, the mixed CDS phase had the highest oral challenge rate (33 vs. 26 vs. 13%) and delabeling rate (43 vs. 33 vs. 27%). No adverse events occurred.CDS tools improve clinician decision-making and optimize patient care. However, relying on CDS for complex clinical evaluations can lead to failure when clinicians cannot find the tool or appreciate its importance. Person-to-person communication can be vital in establishing a process and educating intended users for successful CDS implementation.</p>\",\"PeriodicalId\":48956,\"journal\":{\"name\":\"Applied Clinical Informatics\",\"volume\":\" \",\"pages\":\"1095-1103\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12431808/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Applied Clinical Informatics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2595-4849\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL INFORMATICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Clinical Informatics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2595-4849","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0
摘要
大约10%的患者有青霉素“过敏”记录;然而,高达95%的患者随后检测呈阴性。这些患者可能接受不理想的抗生素治疗,导致住院时间更长、费用更高、耐药率和院内感染率以及全因死亡率。为了减轻儿童的这些风险,我们实施了一项住院青霉素过敏去标签方案,并通过临床决策支持(CDS)的混合方法将其整合到电子健康记录(EHR)中。我们将协议的实施分为三个连续阶段:“试点”、“活性抗菌药物管理计划(ASP)”和“混合CDS”。我们强调几个潜在的陷阱,可能导致不良的临床医生采用。根据病史对患者进行风险分层,分为非过敏、低风险和高风险。过程测量包括:评估率,低风险的口腔挑战率,以及延迟口腔挑战时高风险或低风险的过敏转诊率。主要结局指标为低风险或非过敏人群的青霉素过敏去标签率。平衡措施包括肾上腺素或抗组胺药服用率。试点和ASP阶段使用临床医生教育和订单集,但主要是手动过程。混合CDS阶段引入了中断警报、笔记模板中的动态文本和患者列表栏来指导临床医生,但很少提供教育。与试验和活性ASP阶段相比,混合CDS阶段的评估率最低(6.4% vs 25% vs 15%)。然而,当进行评估时,混合CDS期具有最高的口腔攻毒率(33%对26%对13%)和去贴率(43%对33%对27%)。无不良事件发生。CDS工具可改善临床医生的决策并优化患者护理。然而,当临床医生无法找到工具或认识到其重要性时,依赖CDS进行复杂的临床评估可能导致失败。人与人之间的沟通对于建立流程和教育目标用户以成功实施CDS至关重要。
A Rash Decision: Implementing an EHR-Integrated Penicillin Allergy Delabeling Protocol without Adequate Clinician Support.
Approximately 10% of patients have a documented penicillin "allergy"; however, up to 95% have subsequent negative testing. These patients may receive suboptimal antibiotics, leading to longer hospitalizations and higher costs, rates of resistant and nosocomial infections, and all-cause mortality. To mitigate these risks in children, we implemented an inpatient penicillin allergy delabeling protocol and integrated it into the electronic health record (EHR) through a mixed methods approach of clinical decision support (CDS).We describe our protocol implementation across three sequential phases: "Pilot," "Active Antimicrobial Stewardship Program (ASP)," and "Mixed CDS." We highlight several potential pitfalls that may have contributed to poor clinician adoption.Patients were risk-stratified as nonallergic, low-risk, or high-risk based on history. Process measures included: evaluation rate, oral challenge rate for low-risk, and allergy referral rate for high- or low-risk when oral challenge was deferred. The primary outcome measure was the penicillin allergy delabeling rate among low-risk or nonallergic. Balancing measures included the rate of epinephrine or antihistamine administrations.The pilot and ASP phases used clinician education and an order set, but were mostly manual processes. The mixed CDS phase introduced interruptive alerts, dynamic text in note templates, and patient list columns to guide clinicians, but little education was provided. The mixed CDS phase had the lowest evaluation rate compared with the pilot and active ASP phases (6.4 vs. 25 vs. 15%). However, when the evaluation was performed, the mixed CDS phase had the highest oral challenge rate (33 vs. 26 vs. 13%) and delabeling rate (43 vs. 33 vs. 27%). No adverse events occurred.CDS tools improve clinician decision-making and optimize patient care. However, relying on CDS for complex clinical evaluations can lead to failure when clinicians cannot find the tool or appreciate its importance. Person-to-person communication can be vital in establishing a process and educating intended users for successful CDS implementation.
期刊介绍:
ACI is the third Schattauer journal dealing with biomedical and health informatics. It perfectly complements our other journals Öffnet internen Link im aktuellen FensterMethods of Information in Medicine and the Öffnet internen Link im aktuellen FensterYearbook of Medical Informatics. The Yearbook of Medical Informatics being the “Milestone” or state-of-the-art journal and Methods of Information in Medicine being the “Science and Research” journal of IMIA, ACI intends to be the “Practical” journal of IMIA.